Early Access — free while we kick the tires
EdgarHawk

GDTC CytoMed Therapeutics Ltd Insider Trading

Latest: Director Bought $129K of Shares · May 2026
1 filing analyzed · Latest 2026-06-15
Insider buys
1
Insider sells
0
Unique insiders
1
Direction
Net buying
High conviction

This is a high-conviction signal — the insider is a first-time or occasional buyer, historically the strongest subset. Such buys have outperformed the S&P 500 by a median ~3% over the 30 days after filing (n ≈ 2,994, 2023-2026). Past results don't predict the future. How we measure this ↗

June 2026
2026-06-15
high
Chee Kong Choo Buy
112,000 shares
$128,778
@ $1.15
Significance 6/10

Director Chee Kong Choo bought 112,000 shares of GDTC at $1.15; holdings now 430,324 shares (+35.2%)

Director Chee Kong Choo purchased 112,000 shares at $1.15, increasing his holdings from 318,324 shares to 430,324 shares, a net change of +35.2%. The transaction occurred when the stock was trading at a significant discount: the current price of $1.14 is -69.0% from the 52-week high of $3.68, though the stock has gained +51.0% over the past 30 days. This substantial open-market buy by a director in a small-cap name (market cap $13.5M) represents a meaningful capital commitment at a depressed absolute price level relative to recent highs.

Get alerts for GDTC

Add GDTC to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access